Chandan Healthcare chairman and AGM
NSE: CHANDANHealthcare Services
Share price at the NSE close on 27 Oct 2026. Previous close ₹227.90.
27 Oct: open ₹234.00, high ₹234.90, low ₹225.05
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹584 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,80063.6% delivered
Chandan Healthcare's chairperson is AMAR SINGH, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 30 Sep 2026.
Chandan Healthcare board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonAMAR SINGHRelated to the promoter
- Company Secretary and Compliance OfficerRajeev Kumar Nain
7 directors4 independent2 executive1 non-executive
- AMAR SINGH · ChairpersonExecutive · joined Sep 2003 · reappointed Mar 2024 · 1 listed board · 2 committee seats
- ASMITA SINGHExecutive · joined Sep 2003 · reappointed Mar 2024 · 1 listed board
- VINAY LAMBANon-executive · joined Sep 2003 · 1 listed board · 1 committee seat, 1 as chair
- AMIT GUPTAIndependent · joined Aug 2024 · 25 months as independent · 0 listed boards · 1 as independent · 1 committee seat, 1 as chair
- VINOD JAINIndependent · joined Aug 2024 · 25 months as independent · 0 listed boards · 1 as independent · 2 committee seats
- BRAHMA NAND BHARTIYAIndependent · joined Aug 2024 · 25 months as independent · 0 listed boards · 1 as independent · 2 committee seats
- SANJAY SRIVASTAVAIndependent · joined Sep 2026 · 0 months as independent · 0 listed boards
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 26 Sep 20263 of 6 present0 independent · 18 days in between
- 7 Sep 20264 of 6 present1 independent · 23 days in between
- 14 Aug 20266 of 6 present3 independent · 24 days in between
- 20 Jul 20264 of 6 present1 independent · 6 days in between
3 earlier meetings
- 13 Jul 20263 of 6 present0 independent · 44 days in between
- 29 May 20266 of 6 present3 independent · 36 days in between
- 22 Apr 20266 of 6 present3 independent
Audit Committee
Chair AMIT GUPTA
VINOD JAIN, BRAHMA NAND BHARTIYA, AMAR SINGH
- 6 Sep 20264 of 4 present3 independent · 24 days in between
- 12 Aug 20264 of 4 present3 independent · 29 days in between
- 13 Jul 20264 of 4 present3 independent · 66 days in between
- 7 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair BRAHMA NAND BHARTIYA
AMIT GUPTA, VINOD JAIN, VINAY LAMBA
- 6 Sep 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair VINAY LAMBA
VINOD JAIN, BRAHMA NAND BHARTIYA, AMAR SINGH
- 30 Sep 20264 of 4 present2 independent · 23 days in between
Corporate Social Responsibility Committee
Chair AMAR SINGH
BRAHMA NAND BHARTIYA, VINAY LAMBA
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- MSNT & Associates LLPPeer-review certificate valid to Jan 2029
1 earlier auditor
- MSNT and Associates LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Chandan Healthcare AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.
Annual general meeting, 30 Sep 2026
1,719 shareholders on the register on 25 Sep 2026; present: 9 promoters and 31 others; votes counted by Mr. Akshat Garg / Akshat Garg & Associates.
ORDINARY - To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and Auditors thereon; and b. the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Auditors thereon.-Ordinary ResolutionMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 44.97% · promoters 60.06% · institutions 0.00% · other public 33.24%
- ORDINARY - To appoint a Director in place of Mr. Amar Singh (DIN: 01096328), who retires by rotation and being eligible, offers himself, for re-appointment.- Ordinary ResolutionOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 44.97% · promoters 60.06% · institutions 0.00% · other public 33.24%
- ORDINARY - To ratify remuneration of the Cost Auditor for the financial year ending on March 31, 2027.- Ordinary ResolutionOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 44.97% · promoters 60.06% · institutions 0.00% · other public 33.24%
- SPECIAL - To approve variation in the objects and utilisation of the proceeds of the preferential issue of convertible warrants – Special ResolutionSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 44.97% · promoters 60.06% · institutions 0.00% · other public 33.24%
- SPECIAL - To appoint Mr. Sanjay Srivastava as an Independent Director of the Company - Special ResolutionSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 44.97% · promoters 60.06% · institutions 0.00% · other public 33.24%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 29 Aug 2026, 1 resolution
1,627 shareholders on the register on 22 Aug 2026; present: 6 promoters and 29 others; votes counted by Akshat Garg / Akshat Garg & Associates.The company's voting result
- To consider and approve the disinvestment of the entire shareholding of the company in Chandan Pharmacy Limited.SpecialPromoters have an interest in it99.93% for0.07% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 28.66% · promoters 19.43% · institutions 62.27% · other public 34.98%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesFeb 2025 | 70.45 | Setting up of a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh | 32.82 | 27.65 | No |
| Public IssuesFeb 2025 | 70.45 | Setting up of a new Central Reference laboratory at Ayodhya, Uttar Pradesh | 7.10 | 7.10 | No |
| Public IssuesFeb 2025 | 70.45 | Setting up of a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh | 7.10 | 7.10 | No |
| Public IssuesFeb 2025 | 70.45 | For General Corporate Purpose | 16.72 | 16.72 | No |
| Public IssuesFeb 2025 | 70.45 | Issue related expenses | 6.70 | 6.70 | No |
| Preferential IssuesNov 2025, checked by Crisil Ratings Limited | 104.13 | Business Expansion | 44.50 | 23.38 | No |
| Preferential IssuesNov 2025, checked by Crisil Ratings Limited | 104.13 | Acquisitions | 50.00 | 0.00 | No |
| Preferential IssuesNov 2025, checked by Crisil Ratings Limited | 104.13 | General Corporate Purposes | 9.63 | 4.76 | No |